BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-7 out of 7 found
  Current Search:  casodex: 7     

HTML
100%
Men on Hormone Therapy for Prostate Cancer May Have Greater Cardiovascular Risks
Men who are on androgen-deprivation therapy (ADT) for prostate cancer may have an elevated risk for developing cardiovascular disease, according to an advisory issued jointly by the American Heart Association, the American Cancer Society, and the American...
EMax Health:  Feb 2 2010 5:49PM
Matching: casodex
Find similar documents
HTML
100%
Research and Markets: Drive the Roadmap for Success in Oncology as Global Oncology Market is Projected to Outg
Research and Markets (http://www.researchandmarkets.com/research/d7939f/roadmap_for_succes) has announced the addition of the 'Roadmap for Success in Oncology' report to their offering.

The worldwide oncology market is projected to outgrow the rest of the...

RBC Dain Rauscher:  Feb 2 2010 11:30AM
Matching: casodex
Find similar documents
HTML
100%
Prostate Cancer: Drug Pipeline Update 2010
Published Date: January 2010 Published By: Order Code: R474-385 Description Cancer of the prostate is the second most frequently diagnosed cancer in men in the US.

The prostate cancer market is reaching maturity, and major players' sales have been eroded by...

Mindbranch:  Jan 31 2010 10:14AM
Matching: casodex
Find similar documents
HTML
100%
AstraZeneca issues disappointing guidance
AstraZeneca reported fourth-quarter results in line with our expectations.

However the company issued disappointing 2010 earnings-per-share guidance of $5.75 to $6.15, which is slightly below our projections.

Based on the company's outlook, we will likely...

Morningstar UK:  Jan 28 2010 6:39PM
Matching: casodex
Find similar documents
HTML
100%
AstraZeneca Falls on Disappointing Forecast, Buyback (Update3)
(Adds closing share price in fifth paragraph.) Jan.

28 (Bloomberg) -- AstraZeneca Plc fell the most in more than 10 months in London trading after the U.K.

drugmakers sales forecast and stock buyback disappointed some analysts and fourth-quarter profit...

BusinessWeek:  Jan 28 2010 6:23PM
Matching: casodex
Find similar documents
HTML
100%
AstraZeneca hands global oncology portfolio to Edelman
Edelman has picked up a lucrative account with AstraZeneca to handle its entire global oncology portfolio.

The agency won the brief following a two-way shoot-out against Cohn & Wolfe.

Industry sources suggested the account could be worth up to 500,000....

Brand Republic:  Jan 27 2010 4:40PM
Matching: casodex
Find similar documents
HTML
100%
Commercial Insight: Antihormonal Cancer Therapies - new report released
www.companiesandmarkets.com/Summary-Market-Report/commercial-ins ..

Introduction Antihormonal cancer therapies are a class of drugs used predominantly in the treatment of breast cancer and prostate cancer.

The high incidence of these tumor types translates...

PR inside:  Jan 6 2010 8:58AM
Matching: casodex
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.